The Swiss stock market showed minimal movement, with the SMI down 0.07% to 8215.17 points and the SPI down 0.04% to 8908.21 points. Credit Suisse saw a surprising profit but fell 2.25%, while UBS and Julius Bär also declined. Defensive stocks like Nestlé and Roche had mixed results, and Logitech surged 7.83% in the broader market.
The Swiss stock exchange turned negative, with the SMI down 0.30% to 8060.69 points and the SPI losing 0.37% to 8704.05 points amid low trading volumes. Banking stocks faced pressure, particularly UBS (-1.86%) and Credit Suisse (-1.52%), due to uncertainties around Brexit and low interest rates. Defensive stocks like Novartis (+0.44%) showed resilience, while Sulzer surged 10.59% following its acquisition of Geka.
The Swiss stock market declined, with the SMI Leading Value Index down 0.67% to 8166.01 points amid uncertainty following the Federal Reserve's unchanged benchmark rate. Credit Suisse's surprising profit announcement led to a 3.38% drop in its shares, while UBS and Julius Bär also fell. Logitech surged 15.94% as it reported strong growth for the fiscal year.
The Swiss stock exchange closed sharply lower, with the SMI down 1.54% at 8095.07 points, as investors took profits after recent gains. Credit Suisse saw a significant drop of 5.02% despite reporting a profit for the second quarter, while other major banks and insurance companies also faced declines. In contrast, Logitech surged 13.62% following a strong start to its fiscal year.
The Swiss stock exchange started the week positively, with the SMI Guiding Values Index rising 1.51% to 7982.44 points, while the SPI gained 1.50% to 8311.73 points. The market's optimism is fueled by increasing oil prices, benefiting companies like Transocean and cyclical stocks such as ABB and Adecco. Notable gains were also seen in banking and insurance sectors, with UBS and Swiss Re performing well, while EFG International faced a decline after announcing its acquisition of BSI.
The Swiss stock market is on an upward trend, with the SMI Index rising 1.25% to 7911.11 points and the SPI gaining 1.29% to 8216.60 points. Traders note a stabilization phase despite lingering uncertainties, while stocks like ABB, Adecco, and LafargeHolcim show strong performances. In the luxury sector, Swatch and Richemont benefit from positive expectations for Chinese New Year sales, while Clariant faces pressure due to disappointing figures.
The pharmaceutical and chemical sector constitutes about 40% of Swiss exports, with major companies like Roche and Novartis closely monitoring the implications of a potential second Trump presidency. While there are hopes for biomedical innovation, concerns about public trust in the industry and the impact of proposed healthcare policies loom large, especially regarding drug pricing and the role of scientific research. Trump's administration may also challenge global health initiatives and partnerships, particularly with China, complicating the landscape for Swiss pharmaceutical firms reliant on international trade.
The global regenerative medicine market, valued at USD 31.90 billion in 2023, is projected to grow at a CAGR of 27.06%, reaching USD 349.93 billion by 2033. North America leads the market due to its advanced healthcare infrastructure and increasing demand for personalized medicine, while musculoskeletal conditions are expected to drive the fastest growth. However, high treatment costs and limited insurance coverage pose significant challenges to market expansion.
The global red biotechnology market is projected to grow from $381.01 billion in 2023 to $699.31 billion by 2033, driven by rising chronic disease prevalence and increased healthcare funding. Key players like Pfizer and Amgen are advancing drug development, particularly in precision medicine, despite high trial failure rates. Recent mergers, such as Ipsen's acquisition of Albireo, highlight ongoing consolidation in the sector.
Wall Street showed positive momentum, while the Swiss stock market faced losses, with major companies like Novartis, Roche, and Nestlé declining. In Japan, TDK surged 7% after raising its profit forecast, and Nomura Holdings climbed 8% following a significant quarterly profit increase. Despite these gains, investor caution prevails ahead of the US presidential election, contributing to high volatility in the Nikkei.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
